Extending Biosafety Testing to Gene Therapy Products
To overcome the biosafety challenges posed by viral vectors, biomanufacturers are applying Bac-to-AAV, 2D-HPLC, QbD, LC-MS/MS, and other technologies.
Source: genengnews.com
Stay updated with breaking news from Bioprocess Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To overcome the biosafety challenges posed by viral vectors, biomanufacturers are applying Bac-to-AAV, 2D-HPLC, QbD, LC-MS/MS, and other technologies.